Federal Register of Legislation - Australian Government

Primary content

PB 81 of 2020 Determinations/Health as made
This instrument amends the National Health (Continued Dispensing – Emergency Measures) Determination 2020 to provide for the addition of the listed drug acalabrutinib and for the addition of forms of the listed drugs imipramine and methylphenidate to the list of pharmaceutical benefits that can be supplied as a Continued Dispensing supply.
Administered by: Health
Registered 27 Aug 2020
Tabling HistoryDate
Tabled HR31-Aug-2020
Tabled Senate31-Aug-2020
Date of repeal 08 Dec 2020
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Table of contents.

Commonwealth Coat of Arms of Australia

 

PB 81 of 2020

 

National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2020 (No. 7)

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, and delegate of the Minister for Health make the following determination.

Dated               26 August 2020

 

           

THEA DANIEL                                  

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

 

 

 

 

 

 

                                           

                                           


 

 

 

 

 

Contents

1...... Name

2...... Commencement............................................................................................................................... 1

3...... Authority......................................................................................................................................... 1

4 ..... Schedule.......................................................................................................................................... 1

Schedule 1—Amendments                                                                                                                          2

National Health (Continued Dispensing - Emergency Measures) Determination 2020         2

 

 

 


1  Name

(1) This instrument is the National Health (Continued Dispensing – Emergency Measures) Amendment Determination 2020 (No. 7).

(2) This instrument may also be cited as PB 81 of 2020.

2  Commencement

(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 September 2020.

 

Note:          This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

             (2)  Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

                   This instrument is made under subsection 89A(3) of the National Health Act 1953.

4  Schedules

                   Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.


Schedule 1Amendments

National Health (Continued Dispensing – Emergency Measures) Determination 2020

 

[1]        Schedule 1, after entry for Abiraterone in the form Tablet containing abiraterone acetate 500 mg

insert:

Acalabrutinib

Capsule 100 mg

Oral

[2]        Schedule 1, after entry for Imipramine in the form Tablet containing imipramine hydrochloride 25 mg

insert:

 

Tablet containing imipramine hydrochloride 25 mg USP

Oral

[3]        Schedule 1, after entry for Methylphenidate in the form Capsule containing methylphenidate hydrochloride 40 mg (modified release)

insert:

 

Capsule containing methylphenidate hydrochloride 60 mg (modified release)

Oral